他汀类药物与氯吡格雷相互作用争议的现状

[1] Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials[J] . Naveed Sattar,David Preiss,Heather M Murray,Paul Welsh,Brendan M Buckley,Anton JM de Craen,Sreenivasa Rao Kondapally Seshasai,John J McMurray,Dilys J Freeman,J Wouter Jukema,Peter W Macfarlane,Chris J Packard,David J Stott,Rudi G Westendorp,James Shepherd,Barry R Davis,Sara L Pressel,Roberto Marchioli,Rosa Maria Marfisi,Aldo P Maggioni,Luigi Tavazzi,Gianni Tognoni,John Kjekshus,Terje R Pedersen,

[2] Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein[J] . Paul M. Ridker,Jean MacFadyen,Michael Cressman,Robert J. Glynn.Journal of the American College of Cardiology . 2010 (12)

[3] Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia: Results From the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin （JUPITER） and Meta-Analysis of Women From Primary Prevention Trials[J] . Samia Mora,Robert J. Glynn,Judith Hsia,Jean G. MacFadyen,Jacques Genest,Paul M. Ridker.Circulation . 2010 (9)

[4] Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein: Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin （JUPITER）[J] . Brendan M. Everett,Robert J. Glynn,Jean G. MacFadyen,Paul M Ridker.Circulation . 2010 (1)

[5] Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention[J] . Germano Di Sciascio,Giuseppe Patti,Vincenzo Pasceri,Achille Gaspardone,Giuseppe Colonna,Antonio Montinaro.Journal of the American College of Cardiology . 2009 (6)

[6] Cytochrome p-450 polymorphisms and response to clopidogrel. [J]. Current Atherosclerosis Reports, 2009, 11 (3) : 157 - 160

[7] Lack of Evidence of a Clopidogrel–Statin Interaction in the CHARISMA Trial[J] . Jacqueline Saw,Danielle M. Brennan,Steven R. Steinhubl,Deepak L. Bhatt,Koon-Hou Mak,Keith Fox,Eric J. Topol.Journal of the American College of Cardiology . 2007 (4)

[8] Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention[J] . Giuseppe Patti,Vincenzo Pasceri,Giuseppe Colonna,Marco Miglionico,Dionigi Fischetti,Gennaro Sardella,Antonio Montinaro,Germano Di Sciascio.Journal of the American College of Cardiology . 2007 (12)

[9] A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention [J]. AMERICAN HEART JOURNAL, 2006, 152 (02) : 263 - 269

[10] Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (03) : 285 - 288

[1] Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials[J] . Naveed Sattar,David Preiss,Heather M Murray,Paul Welsh,Brendan M Buckley,Anton JM de Craen,Sreenivasa Rao Kondapally Seshasai,John J McMurray,Dilys J Freeman,J Wouter Jukema,Peter W Macfarlane,Chris J Packard,David J Stott,Rudi G Westendorp,James Shepherd,Barry R Davis,Sara L Pressel,Roberto Marchioli,Rosa Maria Marfisi,Aldo P Maggioni,Luigi Tavazzi,Gianni Tognoni,John Kjekshus,Terje R Pedersen,

[2] Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein[J] . Paul M. Ridker,Jean MacFadyen,Michael Cressman,Robert J. Glynn.Journal of the American College of Cardiology . 2010 (12)

[3] Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia: Results From the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin （JUPITER） and Meta-Analysis of Women From Primary Prevention Trials[J] . Samia Mora,Robert J. Glynn,Judith Hsia,Jean G. MacFadyen,Jacques Genest,Paul M. Ridker.Circulation . 2010 (9)

[4] Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein: Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin （JUPITER）[J] . Brendan M. Everett,Robert J. Glynn,Jean G. MacFadyen,Paul M Ridker.Circulation . 2010 (1)

[5] Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention[J] . Germano Di Sciascio,Giuseppe Patti,Vincenzo Pasceri,Achille Gaspardone,Giuseppe Colonna,Antonio Montinaro.Journal of the American College of Cardiology . 2009 (6)

[6] Cytochrome p-450 polymorphisms and response to clopidogrel. [J]. Current Atherosclerosis Reports, 2009, 11 (3) : 157 - 160

[7] Lack of Evidence of a Clopidogrel–Statin Interaction in the CHARISMA Trial[J] . Jacqueline Saw,Danielle M. Brennan,Steven R. Steinhubl,Deepak L. Bhatt,Koon-Hou Mak,Keith Fox,Eric J. Topol.Journal of the American College of Cardiology . 2007 (4)

[8] Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention[J] . Giuseppe Patti,Vincenzo Pasceri,Giuseppe Colonna,Marco Miglionico,Dionigi Fischetti,Gennaro Sardella,Antonio Montinaro,Germano Di Sciascio.Journal of the American College of Cardiology . 2007 (12)

[9] A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention [J]. AMERICAN HEART JOURNAL, 2006, 152 (02) : 263 - 269

[10] Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (03) : 285 - 288